Session 18: Beyond the Statin: Additional Cholesterol Medications for Lipid Management

Wednesday, December 14, 2022, 12:30 PM - 1:45 PM, Webinar (Online)

AMA PRA Category 1 Credits™ (1.00 hours), Non-Physician (1.00 hours)


Date and Time: Session 18: Wednesday, December 14th, 2022 @ 12:30pm-1:45pm PST 
Zoom Webinar ID: 976 0959 8851 
Webinar Link: https://washington.zoom.us/j/97609598851

Talk Title: Beyond the Statin: Additional Cholesterol Medications for Lipid Management

To go back to the main course page, please click here.

Accreditation with Commendation: The University of Washington School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation: The University of Washington School of Medicine designates this other activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Each session is worth 1.0 credit. You can participate in the live, enduring material and/or both. You can only claim credit once per session (live vs recorded).  In order to receive credit, learners must attend the live webinar OR watch the recorded content.  For webinar recordings, learners must answer pre/post test questions with a 70% pass rate to receive credit.  All learners must complete the post-session assessment to claim credit.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 24 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the University of Washington School of Medicine’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

ACPE Accreditation
The Washington State Pharmacy Association is accredited by the Accreditation Council for Pharmacy Education as aProvider of continuing pharmacy education. Each session is worth 1.0 CPE. To receive credit you must complete the post-session evaluation for each session you attend. At the conclusion of the series, participants should be able to combatclinical and medication inertia around cardiometabolic therapy.

ACPE #: 0130-9999-22-474-H01-P 
0130-9999-22-474-L01-P 

Lisa Tannock, MD is a Professor of Internal Medicine in the division of Endocrinology, Diabetes and Metabolism, and Vice Dean for Faculty Affairs and Development at the University of Kentucky. She obtained her MD and Internal Medicine training at the University of Toronto, Canada, then completed a fellowship in Metabolism, Endocrinology and Nutrition at the University of Washington. Dr Tannock joined the University of Kentucky in 2004. She served as Chief of the Division of Endocrinology from 2007-2021, Associate Director of the Barnstable Brown Diabetes Center (2009-2021) and Associate chair for the Department of Internal Medicine (2014-2019). She is a physician-scientist with a clinical focus on diabetes, hyperlipidemia, and transgender care, and her research activity is focused on the role of inflammation in diabetes associated cardiovascular diseases.

Speaker Disclosure(s):  None

Planner Disclosure(s): 

• Dr. Nicole Ehrhardt, MD is on the Advisory board for Dexcom and Novo Nordisk; Educational Grant: Novo Nordisk and Merck; Investigator: Dexcom
• Dr. Savitha Subramanian, MD is on the advisory board for Abbott Diabetes Care and was formerly on the Advisory board for Akcea Therapeutics and Amarni.
• Laura Montour, MD: none
• Lorena Casas-Wright, MD: none
• Nayan Arora, MD: none

All relevant financial relationships have been mitigated.

Mitigation of Relevant Financial Relationships

University of Washington School of Medicine adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Wednesday, December 14, 2022

We would like to thank NovoNordisk for providing an unrestricted educational grant to support the Cardiometabolic ECHO Program.